middle.news
Optiscan Launches US Breast Cancer Imaging Study with Mayo Clinic
8:25am on Wednesday 22nd of July, 2026 AEST
•
Healthcare
Read Story
Optiscan Launches US Breast Cancer Imaging Study with Mayo Clinic
8:25am on Wednesday 22nd of July, 2026 AEST
Key Points
Research Agreement with Mayo Clinic for breast cancer imaging study
35-patient trial assessing InVue and InForm devices in lumpectomy
Study supports FDA 510(k) submissions planned for H2 2026
Integrated surgical-pathology workflow tested for US market entry
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Optiscan Imaging (ASX:OIL)
OPEN ARTICLE